Aptose Biosciences Inc (APS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 05-2000 | 05-1999 | 05-1998 | 05-1997 | |
| Cash Flows From Operating Activities | ||||
| Depreciation Amortization | 1,777 | 339 | 275 | 363 |
| Accounts receivable | -294 | N/A | N/A | N/A |
| Other Working Capital | 384 | 475 | N/A | 508 |
| Other Operating Activity | -5,445 | -3,255 | -3,295 | -3,483 |
| Operating Cash Flow | $-3,579 | $-2,442 | $-3,021 | $-2,612 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -3,712 | N/A | -137 | N/A |
| Net Acquisitions | -360 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | -5,290 | N/A | -5,660 |
| Sale Of Investment | N/A | N/A | 3,295 | N/A |
| Other Investing Activity | 0 | 0 | -481 | 0 |
| Investing Cash Flow | $-4,072 | $-5,290 | $2,677 | $-5,660 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 34,433 | 4,815 | 1,991 | 5,152 |
| Other Financing Activity | 6,348 | 2,306 | -1,991 | 2,467 |
| Financing Cash Flow | $40,781 | $7,121 | $0 | $7,619 |
| Beginning Cash Position | 859 | 1,831 | 1,236 | 1,959 |
| End Cash Position | 33,989 | 1,221 | 892 | 1,306 |
| Net Cash Flow | $33,130 | $-610 | $-343 | $-653 |
| Free Cash Flow | ||||
| Operating Cash Flow | -3,579 | -2,442 | -3,021 | -2,612 |
| Capital Expenditure | -3,790 | N/A | -137 | N/A |
| Free Cash Flow | -7,368 | -2,442 | -3,158 | -2,612 |